Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
[1] These reactions usually improve after the initial 2 weeks of therapy
As a research injectable peptide, it is not approved by the FDA/EMA/ANSM for therapeutic use
Mirhadi E, Rezaee M, Malaekeh-Nikouei B
BSO inhibits GSH synthesis, thus reducing cellular GSH level
The choice of treatment should be individualised, considering the underlying cause, symptom severity, patient preference, and practical factors such as access to healthcare facilities for regular injections
Efficacy Estimand Change from Baseline HbA1c, source: Additionally, the 12 mg and 36 mg doses demonstrated clinically meaningful and statistically significant reductions in body weight compared to the placebo
US$ 27.86
US$ 24.88
US$ 25.71
US$ 22.12
US$ 22.25
